Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia

Clinical trial NCT01280240 · COMPLETED

Trial details

NCT number

NCT01280240

Sponsor

Pharmacosmos A/S

Status

COMPLETED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2012-03-01

Primary completion

2012-09-01

Enrollment

11

View on ClinicalTrials.gov